Cargando…

Fail-Fast in Respiratory Syncytial Virus Vaccine Development

Detalles Bibliográficos
Autores principales:	Besteman, Sjanna B., Bont, Louis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701037/ https://www.ncbi.nlm.nih.gov/pubmed/30802410 http://dx.doi.org/10.1164/rccm.201901-0233ED

Ejemplares similares

Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step
por: Billard, Marie-Noëlle, et al.
Publicado: (2021)

Respiratory syncytial virus (RSV) disease – new data needed to guide future policy
por: Campbell, Harry, et al.
Publicado: (2015)

Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient
por: Besteman, Sjanna B, et al.
Publicado: (2022)

Neutrophils in respiratory syncytial virus infection: A target for asthma prevention
por: Geerdink, Ruben J., et al.
Publicado: (2015)

An update on respiratory syncytial virus
por: Piralla, Antonio, et al.
Publicado: (2023)

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
por: Simões, Eric A. F., et al.
Publicado: (2015)

Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022)

Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020)

The Changing Landscape of Respiratory Syncytial Virus Infections
por: Bem, Reinout A., et al.
Publicado: (2023)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Gastaldi, Andrea, et al.
Publicado: (2021)

The Respiratory Mucosa: Front and Center in Respiratory Syncytial Virus Disease
por: Thwaites, Ryan S., et al.
Publicado: (2019)

Strategic priorities for respiratory syncytial virus (RSV) vaccine development
por: Anderson, L.J., et al.
Publicado: (2013)

Respiratory Syncytial Virus: Current Progress in Vaccine Development
por: Rudraraju, Rajeev, et al.
Publicado: (2013)

Developing Vaccines against Respiratory Syncytial Virus Infection
por: Chang, Jun
Publicado: (2011)

Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly
por: Blanco, Jorge C. G., et al.
Publicado: (2023)

Respiratory syncytial virus hospitalization and mortality: Systematic review and meta‐analysis
por: Stein, Renato T., et al.
Publicado: (2016)

Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
por: Rozenbaum, Mark H., et al.
Publicado: (2023)

Respiratory Syncytial Virus Infection in High-Risk Infants
por: Resch, Bernhard
Publicado: (2011)

Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle
por: Atkins, Katherine E, et al.
Publicado: (2023)

Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US
por: Zheng, Zhe, et al.
Publicado: (2021)

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood
por: Fauroux, Brigitte, et al.
Publicado: (2017)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
por: Biagi, Carlotta, et al.
Publicado: (2020)

Burden of respiratory syncytial virus bronchiolitis on the Dutch pediatric intensive care units
por: Linssen, Rosalie S., et al.
Publicado: (2021)

The road to approved vaccines for respiratory syncytial virus
por: Ruckwardt, Tracy J.
Publicado: (2023)

Systemic Signature of the Lung Response to Respiratory Syncytial Virus Infection
por: Pennings, Jeroen L. A., et al.
Publicado: (2011)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

Immunoprophylaxis against respiratory syncytial virus with palvizumab: what is new?
por: Sáfadi, Marco Aurélio P.
Publicado: (2014)

[Translated article] Where does Respiratory Syncytial Virus Hide?
por: Martinón-Torres, Federico, et al.
Publicado: (2022)

The Association between Weather Conditions and Admissions to the Paediatric Intensive Care Unit for Respiratory Syncytial Virus Bronchiolitis
por: Linssen, Rosalie S., et al.
Publicado: (2021)

A New Role for CXCL4 in Respiratory Syncytial Virus Disease
por: Wiseman, Dexter J., et al.
Publicado: (2020)

Increased Risk of Wheeze and Decreased Lung Function after Respiratory Syncytial Virus Infection
por: Zomer-Kooijker, Kim, et al.
Publicado: (2014)

Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt
por: De Luca, Daniele, et al.
Publicado: (2023)

Respiratory syncytial virus infection in COVID-19 times: Trick or threat?
por: Menasalvas Ruiz, Ana Isabel
Publicado: (2023)

Respiratory syncytial virus infection in COVID-19 times: Trick or threat?
por: Menasalvas Ruiz, Ana Isabel
Publicado: (2023)

Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study
por: Löwensteyn, Yvette N., et al.
Publicado: (2020)

The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta–analysis
por: Chan, Markus, et al.
Publicado: (2017)

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children
por: Simões, Eric A. F., et al.
Publicado: (2018)

Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
por: Hong, Suyeon, et al.
Publicado: (2021)

Post-extubation stridor in Respiratory Syncytial Virus bronchiolitis: Is there a role for prophylactic dexamethasone?
por: Veldhoen, Esther S., et al.
Publicado: (2017)

Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
por: Blanken, Maarten O., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_49qg4udd1rvsom4peths4tpnrn